The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Severe Aortic Stenosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bernard Prendergast, Prof
St. Thomas Hospital
Principal Investigator - John Webb, MD
St. Paul's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Paul'S Hospital
Vancouver, British Columbia, Canada
- Hamilton Health Sciences
Hamilton, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Québec
Québec, Quebec, Canada
- Kings Hospital
London, United Kingdom
- St. Thomas Hospital
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2018
- Primary completion
- 23 Dec 2019
- Completion
- 21 Jan 2025
- Last update posted
- 18 May 2025
- Registered enrollment
- 100
- Registry id
- NCT03471065
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.